-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MPT-0E028 in Metastatic Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MPT-0E028 in Metastatic Liver Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MPT-0E028 in Metastatic Liver Cancer Drug Details: MPT-0E028 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Chenodiol in Cerebrotendinous Xanthomatosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Chenodiol in Cerebrotendinous Xanthomatosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chenodiol in Cerebrotendinous Xanthomatosis Drug Details: Chenodiol (Xenbilox, Chenix, Chenofalk, Chenodeoxycholic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Chenodiol in Cerebrotendinous Xanthomatosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Chenodiol in Cerebrotendinous Xanthomatosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chenodiol in Cerebrotendinous Xanthomatosis Drug Details: Chenodiol (Xenbilox, Chenix, Chenofalk) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Roneparstat in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Roneparstat in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Roneparstat in Refractory Multiple Myeloma Drug Details: Roneparstat (SST-0001) is under...
-
Product Insights
NewEnterocolitis – Drugs In Development, 2024
Empower your strategies with our Enterocolitis – Drugs In Development, 2024 report and make more profitable business decisions. Enterocolitis is an inflammation of the large and small intestines. Symptoms include fever, abdominal swelling, nausea, diarrhea, rectal bleeding, and sluggishness. Causes of enterocolitis include inflammation of the intestinal tissues, delayed gastric emptying, abdominal wall erythema, apnea, sepsis, and cardiovascular collapse. Treatment includes antibiotics. The Enterocolitis drugs in development market research report provide comprehensive information on the therapeutics under development for Enterocolitis, complete...
-
Product Insights
NewNecrotizing Enterocolitis – Drugs In Development, 2024
Empower your strategies with our Necrotizing Enterocolitis – Drugs In Development, 2024 report and make more profitable business decisions. Necrotizing Enterocolitis is the most common type of infection seen in neonates where inflammation of the intestine leads to mucosal damage causing necrosis or death of cells and tissues. Most observed in premature neonates or in infants weighing less than 1500g leading the mortality rate to greater than 50 percent. Genetic mutations also play a role in this condition. Bacterial invasion into...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Roneparstat in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Roneparstat in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Roneparstat in Refractory Multiple Myeloma Drug Details: Roneparstat (SST-0001) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Chenodiol in Cerebrotendinous Xanthomatosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Chenodiol in Cerebrotendinous XanthomatosisDrug Details:Chenodiol (Xenbilox, Chenix, Chenofalk) is an anticholelithogenic agent which belongs to the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pneumococcal (20-valent) vaccine in Meningitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pneumococcal (20-valent) vaccine in Meningitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pneumococcal (20-valent) vaccine in Meningitis Drug Details: Vaccine is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MP-0317 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MP-0317 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MP-0317 in Endometrial Cancer Drug Details:MP-0317 is under development for the treatment of...